Biotech Co. Cellceutix Hyped Sham Drugs, Class Action Says
A proposed securities class action filed Friday in New York federal court accuses biotechnology company Cellceutix Corp. of fraudulently hyping two of its drugs to inflate stock prices, leading to a...To view the full article, register now.
Already a subscriber? Click here to view full article